On May 31, Shimadzu Corporation made Biomaneo (Location: France, President：Kunihiko Koriyama) a wholly-owned subsidiary. Biomaneo is a software and reagent kit company with strengths in the clinical field. Since 2020, Shimadzu Europa GmbH (SEG), a European subsidiary of our company, has been collaborating with Biomaneo to market software for newborn screening tests (NBS). The purpose […]
Signing of an agreement by Dr. Kimberly Cline, President of Long Island University and Mr. Antoine Turzi, President of RegenLab USA LLC, for the creation of an industrial innovation accelerator dedicated to cell therapies and tissue engineering integrated into the “Dassault Systèmes Center of Excellence” Establishment of a teaching program with Long Island University, with […]
New product features include JMP integration, BLAST, and AlphaFold to drive faster decision-making and better data-driven insights as labs scale their R&D SAN FRANCISCO — Benchling, the R&D Cloud powering the biotechnology industry, today launched new integrations and features that connect data and analytics tools directly in Benchling with just a few clicks, providing scientists with a […]
Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the nomination of Lila Tretikov to its Board of Directors. The Board of Directors has proposed the appointment of Tretikov […]
As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has joined as a founding member of CancerX, a new public-private partnership […]
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]
Company to host webinar featuring tips for managing large-scale proteomics data on UK Biobank Research Analysis Platform MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics […]
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]
Cambridge, UK – Cresset, innovative provider of solutions for CADD, DMTA efficiency and contract research, releases Flare™ V7, a comprehensive drug design platform that integrates the power of ligand and structure-based methods. New features and methods in Flare V7 include significantly enhanced Dynamics and Flare FEP calculations, a new ensemble docking method, enhanced quantitative SAR (QSAR) and Quantum Mechanics (QM) methods, and more tools to troubleshoot Flare […]
The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making Boston, MA – In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
